Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature
This case underscores the need for vigilance regarding autoimmune phenomena such as bullous pemphigoid following coronavirus disease 2019 vaccination. Awareness of such potential adverse effects is crucial to ensure timely diagnosis and management, ultimately contributing to patient safety and guiding future vaccine development.
Authors
- Vivek Sanker (ORCID: https://orcid.org/0000-0003-0615-8397)
- R. Ajith Raj (ORCID: https://orcid.org/0009-0005-1798-0847)
- Tirth Dave (ORCID: https://orcid.org/0000-0001-7935-7333)
- Nishan Wijenaike
- Cherumuttathu H. Suresh (ORCID: https://orcid.org/0000-0001-7237-6638)
- Savitri Chandrasekaran (ORCID: https://orcid.org/0000-0001-9333-7080)
- Mamta Kamboj
- Snigdha Baddepudi
Institutions
- Government Medical College (IN)
- Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital (IN)
- University Hospital Southampton NHS Foundation Trust (GB)
- Bukovinian State Medical University (UA)
- Dayanand Medical College & Hospital (IN)
- Cornwall Regional Hospital (JM)
- West Suffolk Hospital (GB)
- Institute of Medical Sciences (IN)
- Stanford University (US)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s13256-025-05652-x
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47